Neuralstem, Inc. (NYSE Amex: CUR) announced that safety results from the first 12 patients with amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) to receive its stem cells were reported online in the peer-reviewed publication, Stem Cell. "Lumbar Intraspinal Injection of Neural Stem...
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the presentation of favorable clinical data for SAR3419 in the treatment of B-cell...
A report into the care received by nearly 8,000 patients with dementia in 206 hospitals in England and Wales has revealed that few hospitals provide mandatory training for their staff in awareness of dementia, that many patients with dementia are not having assessments of their mental health or...
Abbott (NYSE: ABT) and Bristol-Myers Squibb Company (NYSE: BMY) announced interim results from the Phase 2 portion of a Phase 1b/2 open-label study which showed a high objective response rate (ORR) among patients with relapsed multiple myeloma who received elotuzumab plus lenalidomide and...
The White House on Thursday announced interim final regulations for the new high-risk insurance pools that do not include abortion on the list of services that will be covered, underscoring President Obama's stance that abortion services will not be paid for with federal funds, except in cases...
Surescripts applauds the Drug Enforcement Administration for publishing an interim final rule that will take a meaningful step towards improving patient safety in the United States by allowing the electronic prescribing of controlled substances. The rule attempts to balance the legitimate and...
Surescripts applauds the Drug Enforcement Administration for publishing an interim final rule that will take a meaningful step towards improving patient safety in the United States by allowing the electronic prescribing of controlled substances. The rule attempts to balance the legitimate and...
Helix BioPharma Corp. (TSX, FSE: HBP; Pink Sheets: HXBPF) announced that the first ten patients that have been enrolled in its Phase II pharmacokinetic study of Topical Interferon Alpha-2b in patients with low-grade cervical lesions have completed the pharmacokinetic primary endpoint analyses...
Facet Biotech Corporation (NASDAQ: FACT) and Bristol-Myers Squibb Company (NYSE: BMY) announced that potentially promising data from a Phase I/II study of elotuzumab, an investigational humanized antibody being studied for the treatment of relapsed multiple myeloma (MM), were presented at the...
Can someone explain this to me? What is this title? How does it differ from the UFC Heavyweight championship?
Mir already beat Brock once so what does he have to prove in fighting him again?
im really trying to understand the whole "interim" thing. can anyone explain it to me?
so , randy retired with the belt, nog-mir fought for the "new" belt because it was retired, randy came out of retirement, had not been ebaten, so was still champ, now there are 2 belts, lesnar beat randy for...